Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-Finding of Fluticasone Propionate/Formoterol Fumarate in COPD
NCT00403286Phase 2Completed
- Sponsor
- Dey
- Start
- Nov 2006
- Primary completion
- May 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of fluticasone propionate nasal spray, formoterol in chronic obstructive pulmonary disease (COPD), sponsored by Dey. Started Nov 2006; status: completed.
02
Drugs
fluticasone propionate nasal sprayformoterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00403286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00403286.